UK regulator conditionally authorises triheptanoin for rare inherited metabolic disorders — sources for revision 1
Medicines and Healthcare products Regulatory Agency, GOV.UK
Source date: 2026-10-30.
Supporting location: Opening authorisation paragraph, conditional evidence requirement and prescription status..
Source dates are distinct from Iliyn’s preparation date. Source statements do not independently prove underlying events. No full source articles or source photographs are reproduced.